ACTUALIDAD

Listado de las publicaciones de usuarios del biobanco a partir de las muestras cedidas

  • Carrere J, Rosser AE, Canals JM. HUMAN T-DARPP IS INDUCED DURING STRIATAL DEVELOPMENT. Neuroscience. 2016. 333:320-30. A. IF: 3,3

  • Crovetto F, Triunfo S, Crispi F, Rodriguez-Sureda V, Dominguez C, Figueras F, Gratacos E. DIFFERENTIAL PERFORMANCE OF FIRST TRIMESTER SCREENING IN PREDICTING SMALL FOR GESTATIONAL AGE NEONATES OR FETAL GROWTH RESTRICTION. Ultrasound Obstet Gynecol. 2016. 49(3): 349-356. A. IF: 4,254

  • Crovetto F, Triunfo S, Crispi F, Rodriguez-Sureda V, Roma E, Dominguez C, Gratacos E, Figueras F. FIRST TRIMESTER SCREENING WITH SPECIFIC ALGORITHMS FOR EARLY AND LATE ONSET FETAL GROWTH RESTRICTION. Ultrasound Obstet Gynecol. 2016. 48(3):340-8. A. IF: 4,254

  • Esteban-Jurado C, Franch-Expósito S, Muñoz J, Ocaña T, Carballal S, López-Cerón M, Cuatrecasas M, Vila-Casadesús M, Lozano JJ, Serra E, Beltran S, Brea-Fernández A, Ruiz-Ponte C, Castells A, Bujanda L, Garre P, Caldés T, Cubiella J, Balaguer F, Castellví-Bel S. THE FANCONI ANEMIA DNA DAMAGE REPAIR PATHWAY IN THE SPOTLIGHT FOR GERMLINE PREDISPOSITION TO COLORECTAL CANCER. Eur J Hum Genet. 2016. 24(10): 1501–1505. A. IF: 4,58

  • Flores-Cuadrado A, Ubeda-Bañon I, de la Rosa-Prieto C, Martinez-Marcos A. INTERNEURONS IN THE HUMAN OLFACTORY SYSTEM IN ALZHEIMER'S DISEASE. Exp Neurol. 2016. 276:13-21. A. IF: 1,93

  • Gijselinck I, Van Mossevelde S, Perrone F, Dillen L, Heeman B, Bäumer V, Engelborghs S, De Bleecker J, Baets J, Gelpi E, Rojas-García R, Clarimón J, Lleó A, Diehl-Schmid J, Alexopoulos P, Perneczky R, Synofzik M, Just J, Schöls L, Graff C, Thonberg H, Borroni B, Padovani A, Jordanova A, Sarafov S, Tournev I, de Mendonça A, Miltenberger-Miltényi G, Simões do Couto F, Ramirez A, Jessen F, Heneka MT, Gómez-Tortosa E, Danek A, Cras P, Vandenberghe R, De Jonghe P, De Deyn PP, Sleegers K, Cruts M, Van Broeckhoven C, Goeman J, Nuytten D, Smets K, Robberecht W, Damme PV, Bleecker J, Santens P, Dermaut B, Versijpt J, Michotte A, Ivanoiu A, Deryck O, Bergmans B, Delbeck J, Bruyland M, Willems C, Salmon E, Pastor P, Ortega-Cubero S, Benussi L, Ghidoni R, Binetti G, Hernández I, Boada M, Ruiz A, Sorbi S, Nacmias B, Bagnoli S, Sorbi S, Sanchez-Valle R, Llado A, Santana I, Rosário Almeida M, Frisoni GB, Maetzler W, Matej R, Fraidakis MJ, Kovacs GG, Fabrizi GM, Testi S. TBK1 MUTATION SPECTRUM IN AN EXTENDED EUROPEAN PATIENT COHORT WITH FRONTOTEMPORAL DEMENTIA AND AMYOTROPHIC LATERAL SCLEROSIS. Hum Mutat. 2016. 38(3):297-309. A. IF: 5,08

  • Gulfo J, Ledda A, Gea-Sorlí S, Bonjoch L, Closa D, Grasa M, Esteve M. NEW ROLES FOR CORTICOSTEROID BINDING GLOBULIN AND OPPOSITE EXPRESSION PROFILES IN LUNG AND LIVER. PLoS One. 2016. 11(1):e0146497. A. IF: 4,411

  • Gulfo J, Ledda A, Serra E, Cabot C, Esteve M, Grasa M. ALTERED LIPID PARTITIONING AND GLUCOCORTICOID AVAILABILITY IN CBG-DEFICIENT MALE MICE WITH DIET-INDUCED OBESITY. Obesity. 2016. 24(8):1677-86. A. IF: 3,614

  • Tajes M, ILL-Raga G, Vargas L, Busquets-García A, Bosch-Morató M, Guivernau B, Valls-Comamala V, Gomis M, Grau C, Fandos C, Rosen MD, Rabinowitz MH, Inestrosa N, Maldonado R, Altafaj X, Ozaita A, Alvarez A, Vicente R, Valverde MA and Muñoz FJ. GLUTAMATERGIC STIMULATION INDUCES GLUN2B TRANSLATION BY THE NITRIC OXIDE-HEME-REGULATED EIF2? KINASE IN CORTICAL NEURONS. Oncotarget. 2016. 7(37):58876-58892. A. IF: 5,08

  • Martinez D, Navarro A, Martinez-Trillos A, Molina-Urra R, Gonzalez-Farre B, Salaverria I, Nadeu F, Enjuanes A, Clot G, Costa D, Carrio A, Villamor N, Colomer D, Martinez A, Bens S, Siebert R, Wotherspoon A, Beà S, Matutes E, Campo E. NOTCH1, TP53, AND MAP2K1 MUTATIONS IN SPLENIC DIFFUSE RED PULP SMALL B-CELL LYMPHOMA ARE ASSOCIATED WITH PROGRESSIVE DISEASE. Am J Surg Pathol. 2016. 40(2):192-201. A. IF: 4,951

  • Miranda J, Rodriguez-Lopez M, Triunfo S, Sairanen M, Kouru H, Parra-Saavedra M, Crovetto F, Figueras F, Crispi F, Gratacos E. PREDICTION OF FETAL GROWTH RESTRICTION USING ESTIMATED FETAL WEIGHT VERSUS A COMBINED SCREENING MODEL AT 32–36 WEEKS OF GESTATION. Ultrasound Obstet Gynecol. 2016. doi: 10.1002/uog.17393. A. IF: 4,254

  • Mosquera JL, Ansoleaga B, Ferrer I, Barrachina M. ALTERED MITOCHONDRIAL DNA METHYLATION PATTERN IN ALZHEIMER DISEASE-RELATED PATHOLOGY AND IN PARKINSON DISEASE. Am J Pathol. 2016. 186(2):385-97. A. IF: 4,8

  • Navarro A, Martínez-Pinilla E, Torices S, Tolivia J. APO J AND APO D: COMPLEMENTARY OR ANTAGONISTIC ROLES IN ALZHEIMER'S DISEASE? J Alzheimers Dis. 2016. 53(2):639-50. A. IF: 3,9

  • Ordóñez C, Del Valle E, Navarro A, Tolivia J. REGIONAL AND GENDER STUDY OF NEURONAL DENSITY IN BRAIN DURING AGING AND IN ALZHEIMER'S DISEASE. Front Aging Neurosci. 2016. 8:213. A. IF: 4,3

  • Reig Ò, Marín-Aguilera M, Carrera G, Jiménez N, Paré L, García-Recio S, Gaba L, Pereira MV, Fernández P, Prat A, Mellado B. TMPRSS2-ERG IN BLOOD AND DOCETAXEL RESISTANCE IN METASTATIC CASTRATION-RESISTANT PROSTATE CANCER. Eur Urol. 2016. 70(5):709-713. A. IF: 14,976

  • Ruiz-Lozano T, Vidal J, de Hollanda A, Canteras M, Garaulet M, Izquierdo-Pulido M. EVENING CHRONOTYPE ASSOCIATES WITH OBESITY IN SEVERELY OBESE SUBJECTS: INTERACTION WITH CLOCK 3111T/C. International Journal of Obesity. 2016. 40, 1550–1557. A. IF: 5,337

  • Schmidt J, Gong S, Marafioti T, Mankel B, Gonzalez-Farre B, Balagué O, Mozos A, Cabeçadas J, van der Walt J, Hoehn D, Rosenwald A, Ott G, Dojcinov S, Egan C, Nadeu F, Ramis-Zaldívar JE, Clot G, Bárcena C, Pérez-Alonso V, Endris V, Penzel R, Lome-Maldonado C, Bonzheim I, Fend F, Campo E, Jaffe ES, Salaverria I, Quintanilla-Martinez L. GENOME-WIDE ANALYSIS OF PEDIATRIC-TYPE FOLLICULAR LYMPHOMA REVEALS LOW GENETIC COMPLEXITY AND RECURRENT ALTERATIONS OF TNFRSF14 GENE. Blood. 2016. 128(8):1101-11. A. IF: 11,841

  • Seijo S, Lozano JJ, Alonso C, Miquel R, Berzigotti A, Reverter E, Turon F, Martínez-Chantar ML, Castro A, Mato JM, Hernández-Gea V, Bosch J, García-Pagán JC. METABOLOMICS AS A DIAGNOSTIC TOOL FOR IDIOPATHIC NON-CIRRHOTIC PORTAL HYPERTENSION. Liver Int. 2016. 36(7):1051-8. A. IF: 4,47

  • Ubeda-Bañon I, Saiz-Sanchez D, de la Rosa-Prieto C, Martinez-Marcos A. HIPPOCAMPAL ?-SYNUCLEIN AND INTERNEURONS IN PARKINSON'S DISEASE: DATA FROM HUMAN AND MOUSE MODELS. Mov Disord. 2016. 31(7):979-88. A. IF: 5

  • Van den Bossche T, van der Zee J, Engelborghs S, Sanchez-Valle R, Lladó A, Graff C, Thonberg H, Pastor P, Ortega-Cubero S, Pastor MA, Benussi L, Ghidoni R, Binetti G, Clarimon J, Lleó A, Fortea J, de Mendonça A, Martins M, Grau-Rivera O, Gelpi E, Bettens K, Mateiu L, Dillen L, Cras P, De Deyn PP, Van Broeckhoven C, Sleegers K. A COMPREHENSIVE STUDY OF THE GENETIC IMPACT OF RARE VARIANTS IN SORL1 IN EUROPEAN EARLY-ONSET ALZHEIMER'S DISEASE. Acta Neuropathol. 2016. 132(2):213-24. A. IF: 11,3

  • Vila-Navarro E, Vila-Casadesús M, Moreira L, Duran-Sanchon S, Sinha R, Ginés à, Fernández-Esparrach G, Miquel R, Cuatrecasas M, Castells A, Lozano JJ, Gironella M. MICRORNAS FOR DETECTION OF PANCREATIC NEOPLASIA: BIOMARKER DISCOVERY BY NEXT-GENERATION SEQUENCING AND VALIDATION IN 2 INDEPENDENT COHORTS. Ann Surg. 2016. 265(6):1226-1234. A. IF: 8,569

  • Crovetto F, Figueras F, Crispi F, Triunfo S, Pugia M, Lasalvia L, Chambers AE, Mills WE, Banerjee S, Mercadé I, Casals E, Mira A, Rodriguez-Revenga Bodi L, Gratacós E. FORMS OF CIRCULATING LUTEINIZING HORMONE HUMAN CHORIONIC GONADOTROPIN RECEPTOR FOR THE PREDICTION OF EARLY AND LATE PREECLAMPSIA IN THE FIRST TRIMESTER OF PREGNANCY. Fetal Diagn Ther. 2015. 38(2):94-102. A. IF: 2,7

  • Crovetto F, Figueras F, Triunfo S, Crispi F, Rodriguez-Sureda V, Dominguez C, Llurba E, Gratacós E. FIRST TRIMESTER SCREENING FOR EARLY AND LATE PREECLAMPSIA BASED ON MATERNAL CHARACTERISTICS, BIOPHYSICAL PARAMETERS, AND ANGIOGENIC FACTORS. Prenat Diagn. 2015. 35(2):183-91. A. IF: 3,043

  • Esteban-Jurado C, Vila-Casadesús M, Garre P, Lozano JJ, Pristoupilova A, Beltran S, Muñoz J, Ocaña T, Balaguer F, López-Cerón M, Cuatrecasas M, Franch-Expósito S, Piqué JM, Castells A, Carracedo A, Ruiz-Ponte C, Abulí A, Bessa X, Andreu M, Bujanda L, Caldés T, Castellví-Bel S. WHOLE-EXOME SEQUENCING IDENTIFIES RARE PATHOGENIC VARIANTS IN NEW PREDISPOSITION GENES FOR FAMILIAL COLORECTAL CANCER. Genet Med. 2015. 17(2):131-42. A. IF: 7,71

  • Garcia-Diaz Barriga G, Sanders P, Bombau G, Carrere J, Mairal PB, Vinh NN, Yung S, Kelly CM, Svendsen CN, Kemp PJ, Arjomand J, Schoenfeld RC, Alberch J, Allen ND, Rosser AE, Canals JM. QUANTITATIVE HIGH-THROUGHPUT GENE EXPRESSION PROFILING OF HUMAN STRIATAL DEVELOPMENT TO SCREEN STEM CELL-DERIVED MEDIUM SPINY NEURONS. Mol Ther Methods Clin Dev. 2015. 2:15030. A. IF: 7,04

  • López-Guerra M, Xargay-Torrent S, Rosich L, Montraveta A, Roldán J, Matas-Céspedes A, Villamor N, Aymerich M, López-Otín C, Pérez-Galán P, Roué G, Campo E, Colomer D. THE ?-SECRETASE INHIBITOR PF-03084014 COMBINED WITH FLUDARABINE ANTAGONIZES MIGRATION, INVASION AND ANGIOGENESIS IN NOTCH1-MUTATED CLL CELLS. Leukemia. 2015. 29(1):96-106. A. IF: 12,104

  • Párrizas M, Brugnara L, Esteban Y, González-Franquesa A, Canivell S, Murillo S, Gordillo-Bastidas E, Cussó R, Cadefau JA, García-Roves PM, Servitja JM, Novials A. CIRCULATING MIR-192 AND MIR-193B ARE MARKERS OF PREDIABETES AND ARE MODULATED BY AN EXERCISE INTERVENTION. J Clin Endocrinol Metab. 2015. 100(3):E407-15. A. IF: 6,209

  • Turon F, Cervantes F, Colomer D, Baiges A, Hernández-Gea V, Garcia-Pagán JC. ROLE OF CALRETICULIN MUTATIONS IN THE AETIOLOGICAL DIAGNOSIS OF SPLANCHNIC VEIN THROMBOSIS. J Hepatology. 2015. 62(1):72-4. A. IF: 10,59

  • Van den Bossche T, Engelborghs S, Geerts N, Laureys A, Dillen L, Graff C, Thonberg H, Chiang HH, Pastor P, Ortega-Cubero S, Pastor MA, Diehl-Schmid J, Alexopoulos P, Benussi L, Ghidoni R, Binetti G, Nacmias B, Sorbi S, Sanchez-Valle R, Lladó A, Gelpi E, Almeida MR, Santana I, Tsolaki M, Koutroumani M, Clarimon J, Lleó A, Fortea J, de Mendonça A, Martins M, Borroni B, Padovani A, Matej R, Rohan Z, Vandenbulcke M, Vandenberghe R, De Deyn PP, Cras P, van der Zee J, Sleegers K, Van Broeckhoven C. BELGIUM NEUROLOGY (BELNEU) CONSORTIUM AND THE EUROPEAN EARLY-ONSET DEMENTIA (EU EOD) CONSORTIUM. RARE VARIANTS IN PLD3 DO NOT AFFECT RISK FOR EARLY-ONSET ALZHEIMER DISEASE IN A EUROPEAN CONSORTIUM COHORT. Hum Mutat. 2015. 36(12):1226-35. A. IF: 5,08

  • Van der Zee J, Bettens K, Engelborghs S, Vandenbulcke M, Robberecht C, Dillen L, Merlin C, Geerts N, Graff C, Thonberg H, Chiang HH, Pastor P, Ortega-Cubero S, Pastor MA, Diehl-Schmid J, Alexopoulos P, Benussi L, Ghidoni R, Binetti G, Nacmias B, Sorbi S, Sanchez-Valle R, Lladó A, Gelpi E, Almeida MR, Santana I, Clarimon J, Lleó A, Fortea J, de Mendonça A, Martins M, Borroni B, Padovani A, Mat?j R, Rohan Z, Ruiz A, Frisoni GB, Fabrizi GM, Vandenberghe R, De Deyn PP, Van Broeckhoven C, Sleegers K. BELNEU CONSORTIUM AND OF THE EU EOD CONSORTIUM. GENETIC VARIABILITY IN SQSTM1 AND RISK OF EARLY-ONSET ALZHEIMER DEMENTIA: A EUROPEAN EARLY-ONSET DEMENTIA CONSORTIUM STUDY. Neurobiol Aging. 2015. 36(5):2005. A. IF: 5

  • Veugelen S, Benurwar M, Lismont S, Sepulveda-Falla D, Lleo A, Ryan NS, Lashley T, Fox NC, Murayama S, Gijsen H, De Strooper B, Chávez-Gutiérrez L. QUALITATIVE CHANGES IN HUMAN ?-SECRETASE UNDERLIE FAMILIAL ALZHEIMER'S DISEASE. J Exp Med. 2015. 212(12):2003-13. A. IF: 12,5

  • Botta-Orfila T, Morató X, Compta Y, Lozano JJ, Falgàs N, Valldeoriola F, Pont-Sunyer C, Vilas D, Mengual L, Fernández M, Molinuevo JL, Antonell A, Martí MJ, Fernández-Santiago R, Ezquerra M. IDENTIFICATION OF BLOOD SERUM MICRO-RNAS ASSOCIATED WITH IDIOPATHIC AND LRRK2 PARKINSON'S DISEASE. J Neurosci Res. 2014. 92(8):1071-7. A. IF: 2,594

  • Cabrera JR. Santos-Galindo M. Hoozemans JJ. Ferrer I. Rozemuller AJ. Hernández F. Avila J. Lucas JJ. HUNTINGTON'S DISEASE IS A FOUR-REPEAT TAUOPATHY WITH TAU NUCLEAR RODS. Nat Med. 2014. 20(8):881-5. A. IF: 12,34

  • Canal M. Martín-Flores N. Sun X. Pérez-Fernández V. Wewering S. Fernández-Santiago R. Ezquerra M. Pont-Sunyer C. Lafuente A. Alberch J. Luebbert H. Tolosa E. Levy OA. Greene LA. Malagelada C. PARKIN LOSS OF FUNCTION CONTRIBUTES TO RTP801 ELEVATION AND NEURODEGENERATION IN PARKINSON'S DISEASE. Cell Death Dis. 2014. 5:e1364. A. IF: 5,1

  • Canet-Pons J, Munoz-Marmol AM, Aldecoa I, Lopez MT, Compta Y, Alvarez R, Ispierto L, Tolosa E, Ariza A, Beyer K. CYSTATIN C IS DIFFERENTIALLY INVOLVED IN MULTIPLE SYSTEM ATROPHY PHENOTYPES. Neuropathol Appl Neurobiol. 2014. 41(4):507-19. A. IF: 3,8

  • Canivell S, Ruano EG, Sisó-Almirall A, Kostov B, González-de Paz L, Fernandez-Rebollo E, Hanzu FA, Párrizas M, Novials A, Gomis R. DIFFERENTIAL METHYLATION OF TCF7L2 PROMOTER IN PERIPHERAL BLOOD DNA IN NEWLY DIAGNOSED, DRUG-NAÏVEPATIENTS WITH TYPE 2 DIABETES. PLoS One. 2014. 9(6):e99310. A. IF: 3,234

  • Crovetto F, Figueras F, Triunfo S, Crispi F, Rodriguez-Sureda V, Peguero A, Dominguez C, Gratacos E. ADDED VALUE OF ANGIOGENIC FACTORS FOR THE PREDICTION OF EARLY AND LATE PREECLAMPSIA IN THE FIRST TRIMESTER OF PREGNANCY. Fetal Diagn Ther. 2014. 35(4):258-66. A. IF: 2,939

  • Dehay B, Bové J, Carballo-Carbajal I, Dovero S, Pérez-Villalba A, Fernagut PO, Blesa J, Parent A, Perier C, Fariñas I, Obeso JA, Bezard E, Vila M. LEWY BODY EXTRACTS FROM PARKINSON DISEASE BRAINS TRIGGER ?-SYNUCLEIN PATHOLOGY AND NEURODEGENERATION IN MICE AND MONKEYS. Ann Neurol. 2014. 75(3):351-62. A. IF: 9,6

  • Eraso-Pichot A, Rubio-Moscardó F, Guivernau B, Ramos-Fernández E, Bosch-Morató M, Guix FX, Clarimón J, Miscione G, Boada M, Gil-Gómez G, Suzuki T, Molina H, Villà-Freixa J, Vicente R, Muñoz FJ. METHYLGLYOXAL PRODUCED BY AMYLOID-? PEPTIDE-INDUCED NITROTYROSINATION OF TRIOSEPHOSPHATE ISOMERASE TRIGGERS NEURONAL DEATH IN ALZHEIMER'S DISEASE. J Alzheimers Dis. 2014. 41(1):273-88. A. IF: 3,9

  • Esteban-Jurado C, Garre P, Vila M, Lozano JJ, Pristoupilova A, Beltrán S, Abulí A, Muñoz J, Balaguer F, Ocaña T, Castells A, Piqué JM, Carracedo A, Ruiz-Ponte C, Bessa X, Andreu M, Bujanda L, Caldés T, Castellví-Bel S. NEW GENES EMERGING FOR COLORECTAL CANCER PREDISPOSITION. World J Gastroenterol. 2014. 20(8):1961-1971. A. IF: 2,369

  • Gaig C, Gelpi E, Bataller L, Lewerenz J, Torres-Vega E, Contreras A, Giometto B, Compta Y, Embid C, Vilaseca I, Iranzo A, Santamaría J, Dalmau J, Graus F. A NOVEL NON-RAPID-EYE MOVEMENT AND RAPID-EYE-MOVEMENT PARASOMNIA WITH SLEEP BREATHING DISORDER ASSOCIATED WITH ANTIBODIES TO IGLON5: A CASE SERIES, CHARACTERISATION OF THE ANTIGEN, AND POST-MORTEM STUDY. Lancet Neurol. 2014. 13(6):575-86. A. IF: 23,4

  • Gelpi E, Martín I, Antonell A, Rey M, Grau-Rivera O,: Molinuevo J, Sánchez-Valle R, Lladó A. Catalan collaborative Study Group for FTLD. DIAGNOSTIC ACCURACY OF FTDC BEHAVIORAL VARIANT FRONTOTEMPORAL DEMENTIA CRITERIA IN A CLINICOPATHOLOGICAL COHORT. Neuropathol Appl Neurobiol. 2014. 41(7):882-92. A. IF: 3,8

  • Gómez-Choco M, Doucerain C, Urra X, Planas AM, Chamorro A. PRESENCE OF HEAT SHOCK PROTEIN 70 IN SECONDARY LYMPHOID TISSUE CORRELATES WITH STROKE PROGNOSIS. J Neuroimmunology. 2014. 270(1-2):67-74. A. IF: 2,467
  • Grau-Rivera O, Sánchez-Valle R, Balasa M, Obach V, Amaro S, Rey MJ, Molinuevo JL, Gelpi E, Antonell A. LARGE APP LOCUS DUPLICATION IN A SPORADIC CASE OF CEREBRAL HAEMORRHAGE. Neurogenetics. 2014. 15(2):145-9. A. IF: 3,4

  • Quinzii CM, Hirano M, DiMauro S. MUTANT COQ2 IN MULTIPLE-SYSTEM ATROPHY. N Engl J Med. 2014. 371(1):81. A. IF: 59

  • Kinnersley B, Buch S, Castellví-Bel S, Farrington SM, Forsti A, Hampe J, Hemminki K, Hofstra RM, Northwood E, Palles C, Pinheiro M, Ruiz-Ponte C, Schafmayer C, Teixeira MR, Westers H, Wezel Tv, Bishop DT, Tomlinson I, Dunlop MG, Houlston RS. RE: ROLE OF THE OXIDATIVE DNA DAMAGE REPAIR GENE OGG1 IN COLORECTAL TUMORIGENESIS. J Natl Cancer Inst. 2014. 106(5). A. IF: 12,583

  • López-González I, Thüne K, Carmona M, Zafar S, Andréoletti O, Zerr I, Ferrer I. SUBTYPE AND REGIONAL-SPECIFIC NEUROINFLAMMATION IN SPORADIC CREUTZFELDT-JAKOB DISEASE. Font Aging Neurosci. 2014. 6:198. A. IF: 4,7

  • Mateo F, Meca-Cortés O, Celià-Terrassa T, Fernández Y, Abasolo I, Sánchez-Cid L, Bermudo R, Sagasta A, Rodríguez-Carunchio L, Pons M, Cánovas V, Marín-Aguilera M, Mengual L, Alcaraz A, Schwartz S Jr, Mellado B, Aguilera KY, Brekken R, Fernández PL, Paciucci R, Thomson TM. SPARC MEDIATES METASTATIC COOPERATION BETWEEN CSC AND NON-CSC PROSTATE CANCER CELL SUBPOPULATIONS. Mol Cancer. 2014. 13:237. A. IF: 4,257

  • Miró-Mur F, Ferrer-Ferrer M, Gelpi E, Pedragosa J, Justicia C, Urra X, Chamorro A, Planas AM. NEUTROPHIL RECRUITMENT TO THE BRAIN IN MOUSE AND HUMAN ISCHEMIC STROKE. Acta Neuropathol. 2014. 129(2):239-57. A. IF: 9,4

  • Navarro-Otano J, Tolosa E, Gaig C, Compta Y, Rey MJ, Martí MJ, Hernández I, Valldeoriola F, Reñé R, Ribalta T. MULTIPLE ORGAN INVOLVEMENT BY ALPHA-SYNUCLEIN PATHOLOGY IN LEWY BODY DISORDERS. Mov Disord. 2014. 29(8):1010-8. A. IF: 5

  • Petruzzelli M, Schweiger M, Schreiber R, Campos-Olivas R, Tsoli M, Allen J, Swarbrick M, Rose-John S, Rincon M, Robertson G, Zechner R, Wagner EF. A SWITCH FROM WHITE TO BROWN FAT INCREASES ENERGY EXPENDITURE IN CANCER-ASSOCIATED CACHEXIA. Cell Metabolism. 2014. 20: 1-15. A. IF: 17,565

  • Porta S, Buira SP, Pereira-Veiga S, Díaz-Sánchez S, Albasanz JL, Ferrer I, Martin M, Barrachina M. INCREASED STRIATAL ADENOSINE A2A RECEPTOR LEVELS IN AN EARLY EVENT IN PARKINSTON’S DISEASE RELATED PATHOLOGY AND IT IS POTENTTIALLY REGUALATED BY MIR 34B. Neurobiology Of Disease. 2014. 69:206-14. A. IF: 5,07

  • Rojo-Martínez G, Maymó-Masip E, Rodríguez MM, Solano E, Goday A, Soriguer F, Valdés S, Chaves FJ, Delgado E, Colomo N, Hernández P, Vendrell J, Chacón MR. SERUM SCD163 LEVELS ARE ASSOCIATED WITH TYPE 2 DIABETES MELLITUS AND ARE INFLUENCED BY COFFEE AND WINE CONSUMPTION: RESULTS OF THE DI@BET.ES STUDY. PLoS One. 2014. 9(6):e101250. A. IF: 3,234

  • Ruano EG, Canivell S, Vieira E. REV-ERB ALPHA POLYMORPHISM IS ASSOCIATED WITH OBESITY IN THE SPANISH OBESE MALE POPULATION. PLoS One. 2014. 9(8):e104065. A. IF: 3,234

  • Suh E, Grossman M, Elman L, McCluskey L, Van Swieten JC, Al-Sarraj S, Neumann M, Gelpi E, Ghetti B, Rohrer JD, Halliday G, Van Broeckhoven C, Seilhean D, Shaw PJ, Frosch MP, Alafuzoff I, Antonell A, Bogdanovic N, Brooks W, Cairns NJ, Cooper-Knock J, Cotman C, Cras P, Cruts M, De Deyn PP, DeCarli C, Dobson-Stone C, Engelborghs S, Fox N, Galasko D, Gearing M, Gijselinck I, Grafman J, Hartikainen P, Hatanpaa KJ, Highley JR, Hodges J, Hulette C, Ince PG, Jin LW, Kirby J, Kofler J, Kril J, Kwok JB, Levey A, Lieberman A, Llado A, Martin JJ, Masliah E, McDermott CJ, McKee A, McLean C, Mead S, Miller CA, Miller J, Munoz DG, Murrell J, Paulson H, Piguet O, Rossor M, Sanchez-Valle R, Sano M, Schneider J, Silbert LC, Spina S, van der Zee J, Van Langenhove T, Warren J, Wharton SB, White CL rd, Woltjer RL, Trojanowski JQ, Lee VM, Van Deerlin V, Chen-Plotkin AS. TMEM106B IS A GENETIC MODIFIER OF FRONTOTEMPORAL LOBAR DEGENERATION WITH C9ORF72 HEXANUCLEOTIDE REPEAT EXPANSIONS. Acta Neuropathol. 2014. 127(3):407-18. A. IF: 10,7

  • Tajes M, Palomer E, Ill-Raga G, Bosch-Morató M, Guivernau B, Román-Dégano I, Eraso-Pichot A, Alcolea D, Fortea J, Nuñez L, Paez A, Alameda F, Fernández-Busquets X, Lleó A, Elosúa R, Boada M, Valverde MA, Muñoz FJ. POSTTRANSLATIONAL NITRO-GLYCATIVE MODIFICATIONS OF ALBUMIN IN ALZHEIMER'S DISEASE: IMPLICATIONS IN CYTOTOXICITY AND AMYLOID-? PEPTIDE AGGREGATION. J Alzheimers Dis. 2014. 40(3):643-57. A. IF: 3,9

  • Van der Flier WM, Herold C, Ramonet D, Heilmann S, Lewczuk P, Popp J, Lacour A, Drichel D, Louwersheimer E, Kummer MP, Cruchaga C, Hoffmann P, Teunissen C, Holstege H, Kornhuber J, Peters O, Naj AC, Chouraki V, Bellenguez C, Gerrish A, International Genomics of Alzheimer's Project (IGAP), Alzheimer's Disease Neuroimaging Initiative (ADNI), Heun R, Frölich L, Hüll M, Buscemi L, Herms S, Kölsch H, Scheltens P, Breteler MM, Rüther E, Wiltfang J, Goate A, Jessen F, Maier W, Heneka MT, Becker T, Nöthen MM. SUCLG2 IDENTIFIED AS BOTH A DETERMINATOR OF CSF A?1-42 LEVELS AND AN ATTENUATOR OF COGNITIVE DECLINE IN ALZHEIMER'S DISEASE. Hum Mol Genet. 2014. 23(24):6644-58. A. IF: 6,6

  • Van Langenhove T, Kovacs GG, Dillen L, Deschamps W, Engelborghs S, Mat?j R, Vandenbulcke M, Sieben A, Dermaut B, Smets K, Van Damme P, Merlin C, Laureys A, Van Den Broeck M, Mattheijssens M, Peeters K, Benussi L, Binetti G, Ghidoni R, Borroni B, Padovani A, Archetti S, Pastor P, Razquin C, Ortega-Cubero S, Hernández I, Boada M, Ruiz A, de Mendonça A, Miltenberger-Miltényi G, do Couto FS, Sorbi S, Nacmias B, Bagnoli S, Graff C, Chiang HH, Thonberg H, Perneczky R, Diehl-Schmid J, Alexopoulos P, Frisoni GB, Bonvicini C, Synofzik M, Maetzler W, Vom Hagen JM, Schöls L, Haack TB, Strom TM, Prokisch H, Dols-Icardo O, Clarimón J, Lleó A, Santana I, Almeida MR, Santiago B, Heneka MT, Jessen F, Ramirez A, Sanchez-Valle R, Llado A, Gelpi E, Sarafov S, Tournev I, Jordanova A, Parobkova E, Fabrizi GM, Testi S, Salmon E, Ströbel T, Santens P, Robberecht W, De Jonghe P, Martin JJ, Cras P, Vandenberghe R, De Deyn PP, Cruts M, Sleegers K, Van Broeckhoven C. RARE MUTATIONS IN SQSTM1 MODIFY SUSCEPTIBILITY TO FRONTOTEMPORAL LOBAR DEGENERATION. Acta Neuropathol. 2014. 28(3):397-410. A. IF: 9,7

  • Zafar S, Ansoleaga B, Shafiq M, Blanco R, Carmona M, Grau-Rivera O, Nos C, Gelpí E, Del Río JA, Zerr I, Ferrer I. SUBTYPE AND REGIONAL REGULATION OF PRION BIOMARKERS IN SPORADIC CREUTZFELDT-JAKOB DISEASE. Neuropathol Appl Neurobiol. 2014. 41(5):631-45. A. IF: 3,8

  • Alcolea D, Sánchez-Valle R, Guardia-Laguarta C, Colom-Cadena M, Badiola N, Suárez-Calvet M, Lladó A, Barrera-Ocampo AA, Sepulveda-Falla D, Blesa R, Molinuevo JL, Clarimón J, Ferrer I, Gelpi E, Lleó A. DISTINCT PATTERNS OF APP PROCESSING IN THE CNS IN AUTOSOMAL-DOMINANT AND SPORADIC ALZHEIMER DISEASE. Acta Neuropathol. 2013. 125(2):201-13. A. IF: 9,7

  • Ansoleaga B, Garcia-Esparcia P, Zafar S, Grau-Rivera O, López-González I, Blanco R, Carmona M, Yagüe J, Nos C, Del Río JA, Gelpí E, Zerr I, Ferrer I. PRP MRNA AND PROTEIN EXPRESSION IN BRAIN AND PRPC IN CSF IN CREUTZFELDT-JAKOB DISEASE MM1 AND VV2. Prion. 2013. 7(5):383-93. A. IF: 1,9

  • Benavides-Piccione R, Blazquez-Llorca L, Kastanauskaite A, Rábano A, Avila J, DeFelipe J. THE INFLUENCE OF PHOSPHO-? ON DENDRITIC SPINES OF CORTICAL PYRAMIDAL NEURONS IN PATIENTS WITH ALZHEIMER'S DISEASE. Brain. 2013. 136(Pt 6):1913-28. A. IF: 10

  • Blanch M, Tyebji S, Pereira-Veiga T, Albasanz JL, Martín M, Ferrer I, Pérez-Navarro E and Barrachina M. INCREASED 5-METHYLCYTOSINE AND DECREASED 5-HYDROXYMETHYLCYTOSINE LEVELS ARE ASSOCIATED WITH REDUCED STRIATAL A2AR LEVELS IN HUNTINGTON'S DISEASE. NeuroMolecular Medicine. 2013. 15(2):295-309. A. IF: 3,6

  • Camacho, L., O. Meca-Cortés, J. L. Abad, S. García, N. Rubio, A. Díaz, T. Celià-Terrassa, F. Cingolani, R. Bermudo, P. L. Fernández, J. Blanco, A. Delgado, J. Casas, G. Fabriàs, and T. M. Thomson. ACID CERAMIDASE AS A THERAPEUTIC TARGET IN METASTATIC PROSTATE CANCER. J Lipid Res. 2013. 54: 1207–1220. A. IF: 5,559

  • Canivell S, Ruano EG, Sisó-Almirall A, Kostov B, González-de Paz L, Fernandez-Rebollo E, Hanzu F, Párrizas M, Novials A, Gomis R. GASTRIC INHIBITORY POLYPEPTIDE RECEPTOR METHYLATION IN NEWLY DIAGNOSED, DRUG-NAÏVE PATIENTS WITH TYPE 2 DIABETES: A CASE-CONTROL STUDY. PLoS One. 2013. 8(9):e75474. A. IF: 3,534

  • García-Redondo A, Rojas-García R, Sánchez-Valle R, Noguera A, Gómez-Tortosa E, Pastor P, Hernández I, Esteban-Pérez J, Suárez-Calvet M, Antón-Aguirre S, Amer G, Ortega-Cubero S, Blesa R, Fortea J, Alcolea D, Capdevila A, Antonell A, Lladó A, Muñoz-Blanco JL, Mora JS, Galán-Dávila L, Rodríguez De Rivera FJ, Lleó A, Clarimón J. CHARACTERIZATION OF THE REPEAT EXPANSION SIZE IN C9ORF72 IN AMYOTROPHIC LATERAL SCLEROSIS AND FRONTOTEMPORAL DEMENTIA. Hum Mol Genet. 2013. 23(3):749-54. A. IF: 6,8

  • Gelpi E, Charif S, Belbin O, Blesa R, Martí MJ, Clarimón J, Lleó A. CONFLUENCE OF ?-SYNUCLEIN,TAU,AND ?-AMYLOID PATHOLOGIES IN DEMENTIA WITH LEWY BODIES. J Neuropathol Exp Neurol. 2013. 72(12):1203-12. A. IF: 4,8

  • Guarinos C, Sánchez-Fortún C, Rodríguez-Soler M, Pérez-Carbonell L, Egoavil C, Juárez M, Serradesanferm A, Bujanda L, Fernández-Bañares F, Cubiella J, de-Castro L, Guerra A, Aguirre E, Herreros-de-Tejada A, Bessa X, Herráiz M, Marín-Gabriel JC, Balmaña J, Cuatrecasas M, Balaguer F, Castells A, Soto JL, Alenda C, Payá A, Jover R. CLINICAL SUBTYPES AND MOLECULAR CHARACTERISTICS OF SERRATED POLYPOSIS SYNDROME. Clin Gastroenterol Hepatol. 2013. 11(6):705-11. A. IF: 6,534

  • Jover R, Zapater P, Polanía E, Bujanda L, Lanas A, Hermo JA, Cubiella J, Ono A, González-Méndez Y, Peris A, Pellisé M, Seoane A, Herreros-de-Tejada A, Ponce M, Marín-Gabriel JC, Chaparro M, Cacho G, Fernández-Díez S, Arenas J, Sopeña F, de-Castro L, Vega-Villaamil P, Rodríguez-Soler M, Carballo F, Salas D, Morillas JD, Andreu M, Quintero E, Castells A; COLONPREV study investigators. MODIFIABLE ENDOSCOPIC FACTORS THAT INFLUENCE THE ADENOMA DETECTION RATE IN COLORECTAL CANCER SCREENING COLONOSCOPIES. Gastrointest Endosc. 2013. 77(3):381-389.e1. A. IF: 4,9

  • Kummer MP, Stutz A, Delekate A, Schwartz S, Vieira-Saecker A, Griep A, Axt D, Remus A, Tzeng TC, Gelpi E, Halle A, Korte M, Latz E, Golenbock DT. NLRP3 IS ACTIVATED IN ALZHEIMER'S DISEASE AND CONTRIBUTES TO PATHOLOGY IN APP/PS1 MICE. Nature. 2013. 493(7434):674-8. A. IF: 38,1

  • Lladó A, Altirriba J, Botta-Orfila T, Balasa M, Fernández M, Ferrer I, Sánchez-Valle R, Molinuevo JL. A PRELIMINARY STUDY OF THE WHOLE-GENOME EXPRESSION PROFILE OF SPORADIC AND MONOGENIC EARLY-ONSET ALZHEIMER'S DISEASE. Neurobiol Aging. 2013. 34(7):1772-8. A. IF: 5,01

  • López-Soop G, Gelpi E, Martínez-Vicente M, Alberch J, Pérez-Navarro E. BRAIN REGION- AND AGE-DEPENDENT DYSREGULATION OF P62 AND NBR1 IN A MOUSE MODEL OF HUNTINGTON'S DISEASE. Neurobiol Dis. 2013. 52:219-28. A. IF: 5,07

  • Ortega E, Franch J, Castell C, Goday A, Ribas-Barba L, Soriguer F, Vendrell J, Casamitjana R, Bosch-Comas A, Bordiú E, Calle-Pascual A, Carmena R, Castaño L, Catalá M, Delgado E, Gaztambide S, Girbés J, López-Alba A, Martínez-Larrad MT, Menéndez E, Mora-Peces I, Pascual-Manich G, Rojo-Martínez G, Serrano-Rios M, Urrutía I, Valdés S, Vázquez JA, Gomis R. MEDITERRANEAN DIET ADHERENCE IN INDIVIDUALS WITH PREDIABETES AND UNKNOWN DIABETES: THE DI@BET.ES STUDY. Ann Nutr Metab . 2013. Vol. 62, No. 4, 2013 . A. IF: 2,747

  • Otto C, Lenferink A, Gelpi E, Montenegro GA, Rosandi? J, Tresserra F, Barraquer RI, Vrensen GF. ABSENCE OF AMYLOID-BETA IN LENSES OF ALZHEIMER PATIENTS: A CONFOCAL RAMAN MICROSPECTROSCOPIC STUDY. Exp Eye Res. 2013. 119:44-53. A. IF: 3,08

  • Roeber S, Kretzschmar H, Troakes C, Al-Sarraj S, Gelpi E, Gaig C, Chiu WZ, van Swieten JC, Oertel WH, Höglinger GU. ACCURACY OF THE NATIONAL INSTITUTE FOR NEUROLOGICAL DISORDERS AND STROKE/SOCIETY FOR PROGRESSIVE SUPRANUCLEAR PALSY AND NEUROPROTECTION AND NATURAL HISTORY IN PARKINSON PLUS SYNDROMES CRITERIA FOR THE DIAGNOSIS OF PROGRESSIVE SUPRANUCLEAR PALSY. Mov Disord. 2013. 28(4):504-9. A. IF: 5

  • Rosandi? J, Montenegro GA, Lobato E, Tresserra F, Barraquer RI, Vrensen GF. ABSENCE OF BETA-AMYLOID IN CORTICAL CATARACTS OF DONORS WITH AND WITHOUT ALZHEIMER'S DISEASE. Exp Eye Res. 2013. 106:5-13. A. IF: 3,08

  • Sánchez-Tilló E, de Barrios O, Siles L, Amendola PG, Darling DS, Cuatrecasas M, Castells A, Postigo A. ZEB1 PROMOTES INVASIVENESS OF COLORECTAL CARCINOMA CELLS THROUGH THE OPPOSING REGULATION OF UPA AND PAI-1. Clin Cancer Res. 2013. 19(5):1071-82. A. IF: 8,193

  • van der Zee J, Estrada AT, van Broeckhoven C, Sanchez-Valle R. TARDBP MUTATION P.ILE383VAL ASSOCIATED WITH SEMANTIC DEMENTIA AND COMPLEX PROTEINOPATHY. Neuropathol Appl Neurobiol. 2013. 40(2):225-30. A. IF: 3,8

  • Agell L, Hernández S, Nonell L, Lorenzo M, Puigdecanet E, de Muga S, Juanpere N, Bermudo R, Fernández PL, Lorente JA, Serrano S, Lloreta J. A 12-GENE EXPRESSION SIGNATURE IS ASSOCIATED WITH AGGRESSIVE HISTOLOGICAL IN PROSTATE CANCER: SEC14L1 AND TCEB1 GENES ARE POTENTIAL MARKERS OF PROGRESSION. Am J Pathol . 2012. 181(5):1585-94. A. IF: 4,52

  • Celià-Terrassa T, Meca-Cortés O, Mateo F, de Paz AM, Rubio N, Arnal-Estapé A, Ell BJ, Bermudo R, Díaz A, Guerra-Rebollo M, Lozano JJ, Estarás C, Ulloa C, álvarez-Simón D, Milà J, Vilella R, Paciucci R, Martínez-Balbás M, de Herreros AG, Gomis RR, Kang Y, Blanco J, Fernández PL, Thomson TM. EPITHELIAL-MESENCHYMAL TRANSITION CAN SUPPRESS MAJOR ATTRIBUTES OF HUMAN EPITHELIAL TUMOR-INITIATING CELLS. J Clin Invest. 2012. 122(5):1849-68. A. IF: 12,812

  • Elias-Miró M, Massip-Salcedo M, Raila J, Schweigert F, Mendes-Braz M, Ramalho F, Jiménez-Castro MB, Casillas-Ramírez A, Bermudo R, Rimola A, Rodes J, Peralta C. RETINOL BINDING PROTEIN 4 AND RETINOL IN RAT STEATOTIC AND NON-STEATOTIC LIVERS IN PARTIAL HEPATECTOMY UNDER ISCHEMIA-REPERFUSION. Liver Transpl. 2012. doi: 10.1002/lt.23489. A. IF: 3,944

  • Gelpi E, Martí MJ, Charif S, Blesa R, Dols-Icardo O, Clarimón J, Lleo A. MAPT H1 HAPLOTYPE IS ASSOCIATED WITH ENHANCED -SYNUCLEIN DEPOSITION IN DEMENTIA WITH LEWY BODIES. Neurobiology of Aging. 2012. 34(3):936-42. A. IF: 5,01

  • Gazquez C, Ribal MJ, Marin-Aguilera M, Kayed H, Fernández PL, Mengual L, Alcaraz A. BIOMARKERS VS CONVENTIONAL HISTOLOGICAL ANALYSIS TO DETECT LYMPH NODE MICROMETASTASES IN BLADDER CANCER: A REAL IMPROVEMENT?. BJU Int. 2012. doi: 10.1111/j.1464-410X.2012.11025. A. IF: 3,046

  • Marín-Aguilera M, Codony-Servat J, Kalko SG, Fernández PL, Bermudo R, Buxo E, Ribal MJ, Gascón P, Mellado B. IDENTIFICATION OF DOCETAXEL RESISTANCE GENES IN CASTRATION-RESISTANT PROSTATE CANCER. Mol Cancer Ther. 2012. 11(2):329-39. A. IF: 5,59

  • Munoz-Marmol AM, Sanz C, Marginet-Flinch R, Ferrer I, Ariza A. NEW BRAIN-SPECIFIC BETA-SYNUCLEIN ISOFORMS SHOW EXPRESSION RATIO CHANGES IN LEWY BODY DISEASES. Neurogenetics. 2012. 13(1):61-72. A. IF: 3,4

  • Pagonabarraga J, Houlden H, Pascual-Sedano B, Dols-Icardo O, Tucci A, Paisán-Ruiz C, Campolongo A, Antón-Aguirre S, Martín I, Muñoz L, Bufill E, Vilageliu L, Grinberg D, Cozar M, Blesa R, Lleó A, Hardy J, Kulisevsky J, Clarimón J. GLUCOCEREBROSIDASE MUTATIONS CONFER A GREATER RISK OF DEMENTIA DURING PARKINSON'S DISEASE COURSE. Mov Disord. 2012. 27(3):393-9. A. IF: 5

  • Porta S, Kagerbauer B, Mateu-Huertas E, Pantano L, Ferrer I, Guzmán M, Estivill X, Martí E. A PATHOGENIC MECHANISM IN HUNTINGTON'S DISEASE INVOLVES SMALL CAG-REPEATED RNAS WITH NEUROTOXIC ACTIVITY. PLoS Genet. 2012. 8(2):e1002481. A. IF: 8,5

  • Qu J, Suzuki K, Nivet E, Li M, Montserrat N, Yi F, Xu X, Ruiz S, Zhang W, Wagner U, Kim A, Ren B, Li Y, Goebl A, Kim J, Soligalla RD, Dubova I, Thompson J, Yates J rd, Esteban CR, Sancho-Martinez I, Izpisua Belmonte JC. PROGRESSIVE DEGENERATION OF HUMAN NEURAL STEM CELLS CAUSED BY PATHOGENIC LRRK2. Nature. 2012. 491(7425):603-7. A. IF: 38,1

  • Sánchez-Tilló E, Liu Y, de Barrios O, Siles L, Fanlo L, Cuatrecasas M, Darling DS, Dean DC, Castells A, Postigo A. EMT-ACTIVATING TRANSCRIPTION FACTORS IN CANCER: BEYOND EMT AND TUMOR INVASIVENESS. Cell Mol Life Sci. 2012. 69(20):3429-56. R. IF: 5,615

  • Van der Zee J, Gijselinck I, Dillen L, Van Langenhove T, Theuns J, Engelborghs S, Philtjens S, Vandenbulcke M, Sleegers K, Sieben A, Bäumer V, Maes G, Corsmit E, Borroni B, Padovani A, Archetti S, Perneczky R, Diehl-Schmid J, de Mendonça A, Miltenberger-Miltenyi G, Pereira S, Pimentel J, Nacmias B, Bagnoli S, Sorbi S, Graff C, Chiang HH, Westerlund M, Sanchez-Valle R, Llado A, Gelpi E, Santana I, Almeida MR, Santiago B, Frisoni G, Zanetti O, Bonvicini C, Synofzik M, Maetzler W, Vom Hagen JM, Schöls L, Heneka MT, Jessen F, Matej R, Parobkova E, Kovacs GG, Ströbel T, Sarafov S, Tournev I, Jordanova A, Danek A, Arzberger T, Fabrizi GM, Testi S, Salmon E, Santens P, Martin JJ, Cras P, Vandenberghe R, De Deyn PP, Cruts M, Van Broeckhoven C, van der Zee J, Gijselinck I, Dillen L, Van Langenhove T, Theuns J, Philtjens S, Sleegers K, Bäumer V, Maes G, Corsmit E, Cruts M, Van Broeckhoven C, van der Zee J, Gijselinck I, Dillen L, Van Langenhove T, Philtjens S, Theuns J, Sleegers K, Bäumer V, Maes G, Cruts M, Van Broeckhoven C, Engelborghs S, De Deyn PP, Cras P, Engelborghs S, De Deyn PP, Vandenbulcke M, Vandenbulcke M, Borroni B, Padovani A, Archetti S, Perneczky R, Diehl-Schmid J, Synofzik M, Maetzler W, Müller Vom Hagen J, Schöls L, Synofzik M, Maetzler W, Müller Vom Hagen J, Schöls L, Heneka MT, Jessen F, Ramirez A, Kurzwelly D, Sachtleben C, Mairer W, de Mendonça A, Miltenberger-Miltenyi G, Pereira S, Firmo C, Pimentel J, Sanchez-Valle R, Llado A, Antonell A, Molinuevo J, Gelpi E, Graff C, Chiang HH, Westerlund M, Graff C, Kinhult Ståhlbom A, Thonberg H, Nennesmo I, Börjesson-Hanson A, Nacmias B, Bagnoli S, Sorbi S, Bessi V, Piaceri I, Santana I, Santiago B, Santana I, Helena Ribeiro M, Rosário Almeida M, Oliveira C, Massano J, Garret C, Pires P, Frisoni G, Zanetti O, Bonvicini C, Sarafov S, Tournev I, Jordanova A, Tournev I, Kovacs GG, Ströbel T, Heneka MT, Jessen F, Ramirez A, Kurzwelly D, Sachtleben C, Mairer W, Jessen F, Matej R, Parobkova E, Danel A, Arzberger T, Maria Fabrizi G, Testi S, Ferrari S, Cavallaro T, Salmon E, Santens P, Cras P European Early-Onset. A PAN-EUROPEAN STUDY OF THE C9ORF72 REPEAT ASSOCIATED WITH FTLD: GEOGRAPHIC PREVALENCE, GENOMIC INSTABILITY AND INTERMEDIATE REPEATS. Hum Mutat. 2012. 34(2):363-73. A. IF: 5,08

  • Vogl T, Axt D, Griep A, Vieira-Saecker A, Jessen F, Gelpi E, Roth J, Heneka MT. MRP14 DEFICIENCY AMELIORATES AMYLOID ? BURDEN BY INCREASING MICROGLIAL PHAGOCYTOSIS AND MODULATION OF AMYLOID PRECURSOR PROTEIN PROCESSING. J Neurosci. 2012. 32(49):17824-9. A. IF: 6,3


Cofinanciado por: